Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Bausch & Lomb Surgical's Excimer Laser System Approved
Oct 1999
ROCHESTER, N.Y., Oct. 7 -- Bausch & Lomb announced it has received FDA clearance to market its Keracor 116 excimer laser system, despite the company's plans not to market the system in the US. The system will be restricted to those Investigational Device Exemption users previously recruited to perform the clinical studies.
Hakan Edstrom, senior vice president of Bausch & Lomb and president of its surgical and pharmaceutical divisions, stated, We are pleased with the FDA's decision to grant marketing clearance to the 116, but it is Bausch & Lomb's intent to focus its efforts on securing approval of the Technolas 217 and marketing the advanced laser system in the US. This strategy makes sense given the growing number of LASIK procedures and the fact that the 217 is the only laser specifically designed for the specialized procedure.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.